Production (Stage)
BioScience Health Innovations, Inc.
BHIC
$9.01
-$0.99-9.90%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 342.19% | 134.59% | 113.18% | 76.69% | 1.18% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -- | -- |
| Change in Net Operating Assets | -204.36% | -13.30% | 46.29% | 4.63% | -375.00% |
| Cash from Operations | 238.14% | 107.53% | 105.10% | 70.05% | -16.38% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 70.70% | 56.83% | 98.93% | 165.44% | 208.58% |
| Total Debt Repaid | -55.57% | -87.23% | -116.55% | -323.23% | -451.51% |
| Issuance of Common Stock | 31.82% | 184.91% | -4.41% | 18.52% | 193.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.00% | -100.00% | -100.00% |
| Cash from Financing | 58.86% | 104.79% | -23.48% | -41.53% | 45.04% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,020.24% | 8,254.55% | 744.06% | 414.03% | 894.05% |